Liu, Albert Y.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 5,096

Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.

Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 602

Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study.

Jenness, S. M., Weiss, K. M., Goodreau, S. M., Gift, T., Chesson, H., Hoover, K. W., Smith, D. K., Liu, A. Y., Sullivan, P. S., & Rosenberg, E. S. (2017) · Clinical Infectious Diseases

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 224

Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.

Grohskopf, L. A., Chillag, K. L., Gvetadze, R., Liu, A. Y., Thompson, M., Mayer, K. H., Collins, B. M., Pathak, S. R., O'Hara, B., Ackers, M. L., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 172

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel

Cranston, R. D., Lama, J. R., Richardson, B. A., Carballo-Diéguez, A., Kunjara Na Ayudhya, R. P., Liu, K., Patterson, K. B., Leu, C.-S., Galaska, B., Jacobson, C. E., et al. (2017) · Clinical Infectious Diseases

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 60

Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.

Tang, E. C., Vittinghoff, E., Philip, S. S., Doblecki-Lewis, S., Bacon, O., Chege, W., Coleman, M. E., Elion, R., Buchbinder, S., Kolber, M. A., et al. (2020) · AIDS

HIV/AIDS Research and InterventionsReproductive tract infections research

Cited by 31